CVE-2022-1399

CRITICALCVSS 9.1/10EPSS 0.79%

Last modified

CVE-2022-1399 is a critical-severity vulnerability rated 9.1/10 on the CVSS scale. An Argument Injection or Modification vulnerability in the "Change Secret" username field as used in the Discovery component of Device42 CMDB allows a local attacker to run arbitrary code on the appliance with root privileges. This issue affects: Device42 CMDB version 18.01.00 and prior versions.. EPSS estimates a 0.79% chance of exploitation in the next 30 days.

Description

An Argument Injection or Modification vulnerability in the "Change Secret" username field as used in the Discovery component of Device42 CMDB allows a local attacker to run arbitrary code on the appliance with root privileges. This issue affects: Device42 CMDB version 18.01.00 and prior versions.

Metrics

CVSS 3.1
9.1/10

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H

EPSS Probability
0.79%

51.4th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

VendorProductVersions
Device42Cmdb< 18.01.00

References

Timeline

Published
Last Modified
Status
Modified

Frequently Asked Questions

What is CVE-2022-1399?
An Argument Injection or Modification vulnerability in the "Change Secret" username field as used in the Discovery component of Device42 CMDB allows a local attacker to run arbitrary code on the appliance with root privileges. This issue affects: Device42 CMDB version 18.01.00 and prior versions.
How severe is CVE-2022-1399?
CVE-2022-1399 has a CVSS score of 9.1/10 (CRITICAL severity). The EPSS model estimates a 0.79% probability of exploitation in the next 30 days.
How do I fix CVE-2022-1399?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2022-1399?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST